These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14486356)

  • 41. Hydroxylation and cyclization reactions involved in the metabolism of tri-o-cresyl phosphate.
    ETO M; CASIDA JE; ETO T
    Biochem Pharmacol; 1962; 11():337-52. PubMed ID: 13890904
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of neurotoxic organophosphorus compounds in turkeys.
    Larsen C; Jortner BS; Ehrich M
    J Toxicol Environ Health; 1986; 17(4):365-74. PubMed ID: 3959118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical significance of blood cholinesterase activity in neurologic patients and persons working with organic phosphates].
    Sercl M; Kyral V; Kovarík J; Jakl A; Tulach J; Jindrichová J
    Int Arch Arbeitsmed; 1970; 26(1):63-70. PubMed ID: 4317998
    [No Abstract]   [Full Text] [Related]  

  • 44. Ultrastructural changes in neurons and neuroglia of the avian telencephalon (hyperstriatum accessorium) following tri-ortho-cresyl-phosphate intoxication.
    Spoerri PE; Glees P
    Cell Tissue Res; 1980; 206(2):203-10. PubMed ID: 7388887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Polyneuritis following intramuscular injections of cresyl phosphate].
    ROCHE G; BLANQUIER G; ACHALME J
    J Fr Med Chir Thorac; 1950; 4(5):450-6. PubMed ID: 14803673
    [No Abstract]   [Full Text] [Related]  

  • 46. Neurotoxic esterase and acetylcholinesterase activity in rat nervous system after repeated treatment with triorthocresyl phosphate or oxotremorine.
    Hollingsworth PJ; Smith CB; Richardson RJ
    Dev Toxicol Environ Sci; 1983; 11():495-8. PubMed ID: 6677494
    [No Abstract]   [Full Text] [Related]  

  • 47. Tri-o-cresyl phosphate as a vitamin E antagonist for the rat and lamb.
    DRAPER HH; JAMES MF; JOHNSON BC
    J Nutr; 1952 Aug; 47(4):583-99. PubMed ID: 14955712
    [No Abstract]   [Full Text] [Related]  

  • 48. [Incidence and symptomatology of "Weichigelit" (igelite treated with 3-cresyl phosphate) poisoning].
    WALSDORFF KH
    Dtsch Gesundheitsw; 1951 Jan; 6(4):114-6. PubMed ID: 14812978
    [No Abstract]   [Full Text] [Related]  

  • 49. The significance of background neurologic lesions in acute delayed neurotoxicity studies: a comparison o neurohistopathologic lesions induced in commercial hens by tri-o-tolyl phosphate (TOCP) with those observed in negative control hens.
    Bickford AA; Sprague GL
    Neurotoxicology; 1983; 4(2):283-309. PubMed ID: 6685268
    [No Abstract]   [Full Text] [Related]  

  • 50. [The Moroccan poisoning epidemic of 1959. Myelopolyneuritis caused by tricresylphosphate].
    GEOFFROY H; PASCAL P; SLOMIC A; BENEBADJI M
    Presse Med (1893); 1960 Sep; 68():1474-6. PubMed ID: 13704434
    [No Abstract]   [Full Text] [Related]  

  • 51. [On the "poisoning epidemic" of 1959 in Meknes, Morocco. (Mass poisoning caused by cresyl phosphate)].
    GEOFFROY H; PASCAL P; SLOMIC A
    Munch Med Wochenschr; 1960 Jul; 102():1494-504. PubMed ID: 13827342
    [No Abstract]   [Full Text] [Related]  

  • 52. Observations on the specificity of the inhibition of cholinesterases by tri-orthocresyl phosphate.
    EARL CJ; THOMPSON RH; WEBSTER GR
    Br J Pharmacol Chemother; 1953 Mar; 8(1):110-4. PubMed ID: 13066705
    [No Abstract]   [Full Text] [Related]  

  • 53. Neurotoxic syndrome produced in chickens by a cyclic phosphate metabolite of tri-o-cresyl phosphate--a clinical and pathological study.
    BARON RL; BENNETT DR; CASIDA JE
    Br J Pharmacol Chemother; 1962 Jun; 18(3):465-74. PubMed ID: 13865163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Boutons terminaux and tri-ortho-cresyl phosphate neurotoxicity.
    Illis L; Patangia GN; Cavanagh JB
    Exp Neurol; 1966 Feb; 14(2):160-74. PubMed ID: 5943699
    [No Abstract]   [Full Text] [Related]  

  • 55. Neurologic manifestations of tri-O-cresyl phosphate delayed neurotoxicity in cats.
    Abou-Donia MB; Jensen DN; Lapadula DM
    Neurobehav Toxicol Teratol; 1983; 5(4):431-42. PubMed ID: 6646317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological aspects of tri-o-tolyl phosphate-induced delayed neurotoxicity in chickens.
    Foil LD; Chambers HW; Stinson RS; Glick B
    Toxicol Appl Pharmacol; 1980 Nov; 56(2):259-64. PubMed ID: 6970430
    [No Abstract]   [Full Text] [Related]  

  • 57. [Plasma cholinesterase and erythrocytic acetylcholinesterase in normal children].
    BENAVIDES L; KUMATE J; CRIOLLOS O; CARRILLO J; NAVARRETE JL
    Bol Med Hosp Infant Mex; 1954 Jun; 11(3):265-77. PubMed ID: 13189961
    [No Abstract]   [Full Text] [Related]  

  • 58. [Erythrocytic acetylcholinesterase and serum cholinesterase activity in rats treated with lead nitrate].
    Rausa G; Calapaj GG
    Med Lav; 1970 Nov; 61(11):554-62. PubMed ID: 5508083
    [No Abstract]   [Full Text] [Related]  

  • 59. An outbreak of tri-ortho-cresyl phosphate (T.O.C.P.) poisoning in Durban.
    SUSSER M; STEIN Z
    Br J Ind Med; 1957 Apr; 14(2):111-20. PubMed ID: 13426434
    [No Abstract]   [Full Text] [Related]  

  • 60. Paralysis in Morocco due to triorthocresyl phosphate: a report on the neuromuscular condition of 460 patients.
    LATIMER RM
    J Am Phys Ther Assoc; 1962 Jun; 42():388-96. PubMed ID: 14462684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.